38 results
8-K
EX-99.1
RNAZ
TransCode Therapeutics Inc
1 Apr 22
TransCode Therapeutics Reports 2021 Results; Provides Business Update
4:00pm
the IPO, as well an important Small Business Innovation Research (SBIR) grant, we drove significant progress across the organization, including key … Business Innovation Research (SBIR) grant from National Institutes of Health (NIH), totaling $2.3 million. The award is a fast track award based
8-K
EX-99.1
RNAZ
TransCode Therapeutics Inc
15 Aug 22
TransCode Therapeutics Reports Second Quarter 2022 Results; Provides Business Update
4:09pm
notice of the availability of the second tranche of funding from a Fast-Track Small Business Innovation Research (SBIR) grant we were awarded … financial condition, financial results, and financial expectations including regarding a Small Business Innovation Research grant, achievement of related
8-K
EX-99.1
RNAZ
TransCode Therapeutics Inc
16 May 22
TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
4:03pm
undruggable genetic targets.”
“Additionally, we believe we achieved the first milestone related to our Small Business Innovation Research (SBIR) grant … expectations including regarding a Small Business Innovation Research grant, achievement of related milestones and award of funds thereunder, statements
DEFA14A
RNAZ
TransCode Therapeutics Inc
4 Jan 24
Additional proxy soliciting materials
12:41pm
compromising our commitment to innovation and progress. We have reviewed company operations to identify areas in which we could delay or reduce expenditures … the current economic challenges while preserving the core of our organization.
Despite the headwinds, TransCode remains dedicated to innovation
DRS/A
EX-10.7
RNAZ
TransCode Therapeutics Inc
27 Jan 21
Draft registration statement (amended)
12:00am
knowledge of Hospital’s Innovation office as of the Effective Date, (i) Hospital is the owner by assignment from [**] of the Patent Rights … for Hospital shall be as follows:
If to Hospital:
Chief Innovation Officer, Innovation
Massachusetts General Hospital
215 First Street, Suite 500
S-1
EX-10.7
q2z9o
26 Feb 21
IPO registration
4:06pm
8-K
EX-99.1
5k8xzpcjpboi9xr xilq
23 Aug 21
TransCode Therapeutics Reports Business Progress and Second Quarter 2021 Financial Results
4:55pm
8-K
EX-99.1
2nnzz
14 Nov 22
TransCode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update
4:18pm
DRS/A
EX-10.8
bh8s144quir8vof3
27 Jan 21
Draft registration statement (amended)
12:00am
S-1
EX-10.8
3kal kpie
26 Feb 21
IPO registration
4:06pm
10-K
aawoke1mp cb
31 Mar 22
Annual report
11:19am